Diabetes and cardiovascular disease: explaining the relationship
- PMID: 17938614
Diabetes and cardiovascular disease: explaining the relationship
Abstract
Diabetes is a risk factor for cardiovascular disease. However, even elevated glucose levels below the diabetic range increase cardiovascular risk. There are several possible explanations for this relationship. First, glucose and its metabolites have direct toxic effects on vascular endothelium. Second, abnormal glucose is evidence of absolute or relative insulin deficiency, which can predispose patients to cardiovascular disease via endothelial dysfunction, lipid abnormalities, and inflammation. Third, antecedent factors, such as toxins, abnormal energy storage, and hypertension, may contribute to the development of both diabetes and cardiovascular disease. Whether glucose lowering can reduce the risk of cardiovascular disease is currently being studied in a number of large trials.
Similar articles
-
Role of postprandial hyperglycemia in cardiovascular disease.Expert Rev Cardiovasc Ther. 2008 Jul;6(6):859-72. doi: 10.1586/14779072.6.6.859. Expert Rev Cardiovasc Ther. 2008. PMID: 18570623 Review.
-
From hyperglycemia to the risk of cardiovascular disease.Rev Cardiovasc Med. 2006;7 Suppl 2:S3-9. Rev Cardiovasc Med. 2006. PMID: 17224875 Review.
-
Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk.Semin Vasc Med. 2002 Nov;2(4):383-9. doi: 10.1055/s-2002-36767. Semin Vasc Med. 2002. PMID: 16222628 Review.
-
Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.Diabetes Care. 2008 Feb;31 Suppl 2:S155-60. doi: 10.2337/dc08-s240. Diabetes Care. 2008. PMID: 18227478 Review.
-
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].Ugeskr Laeger. 2003 Aug 11;165(33):3149-53. Ugeskr Laeger. 2003. PMID: 12968409 Review. Danish.
Cited by
-
Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?Diabetologia. 2011 Feb;54(2):230-2. doi: 10.1007/s00125-010-1968-5. Epub 2010 Nov 20. Diabetologia. 2011. PMID: 21103981 No abstract available.
-
Role of Psychological Distress in the Assessment of Chronic Illness Care and Self-Management Behaviors of Elderly Patients with T2DM Chronic Complications.Diabetes Metab Syndr Obes. 2025 Jan 22;18:185-196. doi: 10.2147/DMSO.S498507. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 39866523 Free PMC article.
-
Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism.Front Endocrinol (Lausanne). 2020 Jun 25;11:415. doi: 10.3389/fendo.2020.00415. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32670199 Free PMC article. Clinical Trial.
-
Glucose Response during the Night Is Suppressed by Wheat Albumin in Healthy Participants: A Randomized Controlled Trial.Nutrients. 2019 Jan 17;11(1):187. doi: 10.3390/nu11010187. Nutrients. 2019. PMID: 30658460 Free PMC article. Clinical Trial.
-
Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis.PLoS One. 2012;7(6):e38713. doi: 10.1371/journal.pone.0038713. Epub 2012 Jun 15. PLoS One. 2012. PMID: 22719926 Free PMC article.